Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

mammography.jpg

States move breast cancer screening bills forward

The bills update the ages at which insurance carriers are required to cover screening mammograms and add language that includes tomosynthesis in the definition of mammographic screening.

March 21, 2022
Stacey Wolfson, MD, chief resident, and Beatriu Reig, MD, MPH, clinical assistant professor of radiology, Department of Radiology, NYU Grossman School of Medicine, explain the findings of a study they were the lead authors on published in Radiology. Their study looked at 1,200 women who were vaccinated and received breast imaging exams, and they found several cancers, so their conclusion is not to wait for breast imaging after receiving a COVID vaccine or booster.

VIDEO: Should women wait to get mammograms after COVID vaccination?

In an exclusive video, Stacey Wolfson, MD, and Beatriu Reig, MD, MPH, from the NYU Grossman School of Medicine, discuss the findings of their new analysis. 

March 14, 2022
Examples of two lung cancers that were caught using low dose CT lung screening. Image from RSNA

Q&A: What updated reimbursement policies could mean for CT lung screening rates in the United States

The ACR said a recent reimbursement rule change for low-dose computed tomography (CT) lung screen scans will help open up screening to more patients. 

March 11, 2022

Breast cancer is overdiagnosed in 15% of screenings

Breast cancer overdiagnosis rates are down from previous estimates, but still occur in 1 of every 7 screenings, new research indicates.

March 1, 2022

Around the web

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible. 

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.

Trimed Popup
Trimed Popup